Published in J Pediatr on January 01, 1992
Lead poisoning: case studies. Br J Clin Pharmacol (2002) 1.04
Role of chelating agents for prevention, intervention, and treatment of exposures to toxic metals. Environ Health Perspect (1995) 1.00
Description of 3,180 courses of chelation with dimercaptosuccinic acid in children ≤ 5 y with severe lead poisoning in Zamfara, Northern Nigeria: a retrospective analysis of programme data. PLoS Med (2014) 0.91
The scientific basis for chelation: animal studies and lead chelation. J Med Toxicol (2013) 0.88
Low lead levels stunt neuronal growth in a reversible manner. Proc Natl Acad Sci U S A (1996) 0.88
Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults. Environ Health Perspect (1995) 0.83
Oral succimer decreases the gastrointestinal absorption of lead in juvenile monkeys. Environ Health Perspect (2001) 0.82
Reductions in blood lead overestimate reductions in brain lead following repeated succimer regimens in a rodent model of childhood lead exposure. Environ Health Perspect (2004) 0.82
Comparative study on the hepatoprotection to heavy metals of Zingiber officinale. Pharmacognosy Res (2012) 0.82
Children with moderately elevated blood lead levels: a role for other diagnostic tests? Environ Health Perspect (1997) 0.81
Developmental lead exposure induces tactile defensiveness in rhesus monkeys (Macaca mulatta). Environ Health Perspect (2008) 0.79
Effect of succimer on growth of preschool children with moderate blood lead levels. Environ Health Perspect (2004) 0.78
Lead poisoning from an unexpected source in a 4-month-old infant. Environ Health Perspect (1998) 0.77
Neuroprotective effect of Tagara, an Ayurvedic drug against methyl mercury induced oxidative stress using rat brain mitochondrial fractions. BMC Complement Altern Med (2015) 0.75
Tumour-suppressor activity of H19 RNA. Nature (1993) 3.06
Lead exposure and intelligence in 7-year-old children: the Yugoslavia Prospective Study. Environ Health Perspect (1997) 2.88
Complete primary repair of exstrophy. J Urol (1999) 2.39
Aneurysm sac pressure measurements after endovascular repair of abdominal aortic aneurysms. J Vasc Surg (2001) 2.27
Alternatives to appendix in construction of a Mitrofanoff stoma. J Urol (1998) 2.01
Alteration of iron homeostasis following chronic exposure to manganese in rats. Brain Res (1999) 1.68
How can obese weight controllers minimize weight gain during the high risk holiday season? By self-monitoring very consistently. Health Psychol (1999) 1.67
Subgenual cingulate cortex volume in first-episode psychosis. Am J Psychiatry (1999) 1.59
The syndrome of dysuria and hematuria in pediatric urinary reconstruction with stomach. J Urol (1993) 1.51
Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system. Am J Pathol (1990) 1.51
Experience with the electrohydraulic disintegrator. J Urol (1977) 1.42
t(11;22)(q23;q11.2) In acute myeloid leukemia of infant twins fuses MLL with hCDCrel, a cell division cycle gene in the genomic region of deletion in DiGeorge and velocardiofacial syndromes. Proc Natl Acad Sci U S A (1998) 1.41
Pseudoureterocele: potential for misdiagnosis of an ectopic ureter as a ureterocele. Br J Urol (1995) 1.40
Gastrocystoplasty in children. Eur Urol (1994) 1.40
Dose-response study of oral 2,3-dimercaptosuccinic acid in children with elevated blood lead concentrations. J Pediatr (1988) 1.38
A clinical evaluation of antimicrobial agents and temporary starvation in the treatment of acute undifferentiated diarrhea in newborn calves. Can Vet J (1975) 1.36
Imprinting of human H19: allele-specific CpG methylation, loss of the active allele in Wilms tumor, and potential for somatic allele switching. Am J Hum Genet (1993) 1.36
The McLean-Harvard first-episode project: 6-month symptomatic and functional outcome in affective and nonaffective psychosis. Biol Psychiatry (2000) 1.28
Impact of exclusion criteria on patient selection for endovascular abdominal aortic aneurysm repair. J Vasc Surg (2001) 1.27
Gastrocystoplasty: an alternative solution to the problem of urological reconstruction in the severely compromised patient. J Urol (1988) 1.19
Clozapine in the treatment of refractory psychotic mania. Am J Psychiatry (2000) 1.15
Indiana continent urinary reservoir. J Urol (1987) 1.14
Anti-neutrophil-elastase defenses of the lower respiratory tract in alpha 1-antitrypsin deficiency directly augmented with an aerosol of alpha 1-antitrypsin. Ann Intern Med (1989) 1.12
Altered systemic iron metabolism in Parkinson's disease. Neurology (1997) 1.11
Fibronectin in multiple sclerosis lesions. Am J Pathol (1989) 1.08
Lower urinary tract changes after early valve ablation in neonates and infants: is early diversion warranted? J Urol (1997) 1.08
Induction of cloacal exstrophy in the chick embryo using the CO2 laser. J Urol (1985) 1.02
Intestinocystoplasty and total bladder replacement in children and young adults: followup in 129 cases. J Urol (1987) 1.02
Investigation of somatic NKX2-5 mutations in congenital heart disease. J Med Genet (2009) 1.01
Laparoscopic and histologic evaluation of the inguinal vanishing testis. Urology (1998) 0.99
Voiding dysfunction after bilateral extravesical ureteral reimplantation. J Urol (1998) 0.98
Lead exposure promotes translocation of protein kinase C activities in rat choroid plexus in vitro, but not in vivo. Toxicol Appl Pharmacol (1998) 0.98
Dietary iron, animal fats, and risk of Parkinson's disease. Mov Disord (1998) 0.96
Carnitine metabolism in human subjects. I. Normal metabolism. Am J Clin Nutr (1978) 0.95
Telephone versus in-person clinical and health status assessment interviews in patients with bipolar disorder. Harv Rev Psychiatry (1998) 0.94
A human in vivo model for the determination of lead bioavailability using stable isotope dilution. Environ Health Perspect (1996) 0.91
Long-term followup of the hematuria-dysuria syndrome. J Urol (2000) 0.91
A pilot study of plasma metabolomic patterns from patients treated with ketamine for bipolar depression: evidence for a response-related difference in mitochondrial networks. Br J Pharmacol (2014) 0.91
Use of a double cuff AMS800 urinary sphincter for severe stress incontinence. J Urol (1993) 0.90
Histology of the urethral plate: implications for hypospadias repair. J Urol (2000) 0.90
Blood dyscrasias with carbamazepine and valproate: a pharmacoepidemiological study of 2,228 patients at risk. Am J Psychiatry (1995) 0.88
Endovascular AAA repair in patients with renal insufficiency: strategies for reducing adverse renal events. Cardiovasc Surg (2001) 0.88
Aggressive surgical and medical management of autosomal recessive polycystic kidney disease. Urology (1993) 0.88
Core Standards of the EUBIROD Project. Defining a European Diabetes Data Dictionary for Clinical Audit and Healthcare Delivery. Methods Inf Med (2015) 0.87
Ventral preputial island flap technique for the repair of epispadias with or without exstrophy. J Urol (1984) 0.86
Enteric mucosal regrowth after bladder augmentation using demucosalized gut segments. J Urol (1997) 0.86
Blood lead and blood pressure in young children. Epidemiology (1996) 0.86
Genitourinary neurofibromatosis in childhood. J Urol (1983) 0.86
Intrapleural streptokinase in management of parapneumonic effusions. Report of series and review of literature. J Fla Med Assoc (1989) 0.86
Failure of endovascular abdominal aortic aneurysm graft limbs. J Vasc Surg (2001) 0.85
Hypospadias repair without a bladder drainage catheter. J Urol (1986) 0.85
A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. J Affect Disord (2001) 0.85
Thermography in mass screening for occult breast cancer. JAMA (1968) 0.85
Gender-related differences in infrarenal aortic aneurysm morphologic features: issues relevant to Ancure and Talent endografts. J Vasc Surg (2001) 0.85
Therapeutic thrombin injection of pseudoaneurysms: a multicenter experience. Vasc Med (2001) 0.85
Demucosalized augmentation gastrocystoplasty with bladder autoaugmentation in pediatric patients. J Urol (1996) 0.84
The urological manifestations of epidermolysis bullosa. J Urol (1986) 0.84
Measurement strategies in social support: a descriptive review of the literature. J Clin Psychol (1993) 0.84
Surgical correction of ureteroceles. J Urol (1979) 0.84
The Mitrofanoff principle in urinary reconstruction. J Urol (1993) 0.84
Renal transplantation into the dysfunctional bladder: the role of adjunctive bladder reconstruction. J Urol (1994) 0.84
Metabolism of meso-2,3-dimercaptosuccinic acid in lead-poisoned children and normal adults. Environ Health Perspect (1995) 0.83
Intestinocystoplasty in combination with clean intermittent catheterization in the management of vesical dysfunction. J Urol (1986) 0.83
Vitamin B-6 requirement and status assessment of young women fed a high-protein diet with various levels of vitamin B-6. Am J Clin Nutr (1998) 0.82
Long term effects of gastrocystoplasty in rats. J Urol (1990) 0.82
Perirenal urinary extravasation associated with urethral valves in infants. J Urol (1980) 0.81
Urodynamic evaluation and long-term results of the orthotopic gastric neobladder in men. J Urol (2000) 0.81
Urinary, plasma, and erythrocyte carnitine concentrations during transition to a lactoovovegetarian diet with vitamin B-6 depletion and repletion in young adult women. Am J Clin Nutr (1998) 0.81
Complete primary repair of exstrophy. Surgical technique. Urol Clin North Am (2000) 0.81
Insulin action enhancement normalizes brachial artery vasoactivity in patients with peripheral vascular disease and occult diabetes. J Vasc Surg (1998) 0.80
The role of bladder augmentation in undiversion. J Pediatr Surg (1981) 0.80
The role of magnetic resonance angiography for endoprosthetic design. J Vasc Surg (2001) 0.80
Urologic manifestations of Wegener granulomatosis. Urology (1978) 0.80
Carnitine metabolism in human subjects. II. Values of carnitine in biological fluids and tissues of "normal" subjects. Am J Clin Nutr (1978) 0.80
Multicystic dysplastic kidneys suggesting hydronephrosis during Tc-DTPA imaging. J Nucl Med (1982) 0.80
Gastrocystoplasty and colocystoplasty in canines: the metabolic consequences of acute saline and acid loading. J Urol (1987) 0.79
Hyperproduction of erythropoietin in nonanemic lead-exposed children. Environ Health Perspect (1998) 0.79
Minimally invasive direct access mitral valve surgery. Semin Thorac Cardiovasc Surg (1999) 0.79
Control of massive prostatic bleeding with angiographic techniques. J Urol (1976) 0.79
Treatment of bladder dysfunction in children with end-stage renal disease. J Pediatr Surg (1992) 0.79
Urinary transforming growth factor-alpha in individuals exposed to arsenic in drinking water in Bangladesh. Biomarkers (2001) 0.79
Vaginal calculi secondary to partial vaginal outlet obstruction in pediatric patients. J Urol (2000) 0.79
Preventing teenage pregnancy: some questions to be answered and some answers to be questioned. Pediatr Ann (1993) 0.79
Peptide growth factors and signal transduction. Semin Vasc Surg (1998) 0.78
The Mitrofanoff catheterizable channel: patient acceptance. J Urol (1995) 0.78
Tibia lead levels and methodological uncertainty in 12-year-old children. Environ Res (2001) 0.78
Improved results using a modification of the Young-Dees-Leadbetter bladder neck repair. Br J Urol (1993) 0.78
Gastric bladder reconstruction. Urol Clin North Am (1991) 0.78
A unique new model to study the effects of urinary diversion in the developing rabbit bladder. J Urol (1998) 0.78
Newborn exstrophy closure and epispadias repair. World J Urol (1998) 0.77
Complete primary closure of bladder exstrophy. Epispadias and bladder exstrophy repair. Urol Clin North Am (1999) 0.77
Chronic renal failure and bladder augmentation: stomach versus sigmoid colon in the canine model. J Urol (1988) 0.77
Liver function in protein-energy malnutrition measured by cinnamic acid tolerance and benzoic acid tolerance: effect of carnitine supplementation. Br J Nutr (1989) 0.77
Autoaugmentation peritoneocystoplasty in a sheep model. BJU Int (2001) 0.76
Renal transplantation into the reconstructed bladder. J Urol (1989) 0.76
Continent gastric tube: new techniques and long-term followup. J Urol (1997) 0.76
Bladder augmentation with urothelial preservation. J Urol (1999) 0.76